GLOBAL RESEARCH ARCHIVE
Q1 results out; execution on track
Research evidence excerpt
Q1 results out; execution on track
Diversified Financial Services
Mutares SE & Co. KGaA (MUX GR)
EQUITY RESEARCH Quick Take
May 12, 2026
Q1 results out; execution on track Price: €26.25
Price Target: €48.00 Takeaways
Rating: Overweight In a nutshell: a solid operational quarter, but the real story is on the
Key Statistics: transaction side.
Symbol XETRA: MUX GR
Q1 2026 Group revenues of €1,678.7m (+10% yoy) are run-rate wise 52-Week Range 20.41 - 36.69
Market Cap 672.5 below eCF FY26E of €8.4bn, supported by acquisition-driven perimeter
ADV (3 mo) 109,804 expansion but not yet including the landmark SABIC deal signed in
Shares Out (M) 25.6 January, with annual revenues of approximately €2bn and equity of €2bn
expected to close at the end of Q2.
Research Analysts:
Marie-Thérèse Gruebner More importantly, adjusted EBITDA swung to €11.1m from €-30.1m in Q1
Cantor Europe 2025, which validates the portfolio improvement thesis we have been
+49 69 50 9540640 outlining in recent updates. Marie.Therese.Gruebner@cantor.com
Management reiterates FY26 guidance, which is underpinned by a very
One-Year Price History promising exit pipeline in highly attractive verticals.
35 Summary
30 Q1 Group revenues & EBITDA: the trajectory is what matters. Group
25 revenues grew 10% to €1,678.7m, driven primarily by acquisitions, as
05/25 08/25 11/25 02/26 05/26 well operational turnarounds. Reported EBITDA of €162.4m compares to
MUX GR Created by BlueMatrix €379.7m in Q1 2025, with the prior-year base heavily inflated by bargain
purchase income courtesy of buoyant deal activity.
The operationally clean metric, adjusted EBITDA, tells a materially
better story at €11.1m vs. €-30.1m prior year: a meaningful inflection
showing turnaround progress. Positive contributors include Magirus,
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer